Cargando…

PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical Trials

Risk-adaptive therapy for Hodgkin's lymphoma focuses on treatment modifications based on assessment of response. [(18)F]Fluoro-deoxyglucose positron emission tomography (PET) performed during or after completion of chemotherapy is a strong prognostic factor for eventual treatment outcome. Conce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aridgides, Paul, Bogart, Jeffrey, Shapiro, Anna, Gajra, Ajeet
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017897/ https://www.ncbi.nlm.nih.gov/pubmed/21234382 http://dx.doi.org/10.1155/2011/309237

Ejemplares similares

Heterogeneous Versus Homogeneous Radiation Dose Calculations of Twice-Daily Fractionation in Small Cell Lung Carcinoma
por: Thibodeau, Ryan, et al.
Publicado: (2021)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

PET-guided treatment in advanced-stage Hodgkin lymphoma: yes but which one?
por: Rossi, Cédric, et al.
Publicado: (2019)

PET/CT and brown fat in the evaluation of treatment response in Hodgkin lymphoma
por: Pessanha, Laís Bastos, et al.
Publicado: (2015)

Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials
por: Feinberg, Bruce A., et al.
Publicado: (2021)

Evidence of Inbreeding in Hodgkin Lymphoma
por: Thomsen, Hauke, et al.
Publicado: (2016)

The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments
por: Bari, Alessia, et al.
Publicado: (2019)

PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial
por: Picardi, M., et al.
Publicado: (2021)

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial
por: Georgi, Thomas W., et al.
Publicado: (2020)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
por: Lang, Noemie, et al.
Publicado: (2020)

Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin’s Lymphoma
por: Fueger, Barbara J., et al.
Publicado: (2009)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
por: Chohan, Karan L., et al.
Publicado: (2022)

Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies
por: Deck, Jared, et al.
Publicado: (2019)

Case Report: Use of PET/CT to Guide Treatment in a Cat With Presentation Consistent With Hodgkin's-Like Lymphoma
por: Chen, Carolyn L., et al.
Publicado: (2021)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
por: Milgrom, Sarah A., et al.
Publicado: (2019)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions
por: Georgi, Thomas W., et al.
Publicado: (2023)

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
por: Richter, Julia, et al.
Publicado: (2019)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

P1076: A RETROSPECTIVE ANALYSIS ON OLD AND EMERGING PROGNOSTIC FACTORS IN CLASSICAL HODGKIN’S LYMPHOMA IN THE PET-GUIDED ERA
por: Cellini, A., et al.
Publicado: (2022)

Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy for stage I non-small-cell lung cancer
por: Aridgides, Paul, et al.
Publicado: (2018)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
por: Montoya, Roberto C., et al.
Publicado: (2012)

A Letter in Support of Real-World RECIST
por: Gajra, Ajeet, et al.
Publicado: (2020)

Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients
por: Furth, Christian, et al.
Publicado: (2013)

Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis
por: Feinberg, Bruce, et al.
Publicado: (2020)

Occipital Hypometabolism on FDG PET/CT Scan in a Child with Hodgkin's Lymphoma
por: Uslu Biner, Inci, et al.
Publicado: (2016)

Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT
por: Rossi, Cédric, et al.
Publicado: (2017)

[(18)F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
por: Kanoun, Salim, et al.
Publicado: (2018)

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
por: Gallamini, Andrea, et al.
Publicado: (2021)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

Axillary lymph nodes on PET in Hodgkin lymphoma after COVID‐19 vaccination
por: Arens, Anne I. J., et al.
Publicado: (2021)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
por: Seshachalam, Arun, et al.
Publicado: (2019)

Pathobiology of Hodgkin Lymphoma
por: Piccaluga, Pier Paolo, et al.
Publicado: (2011)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020)

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2016)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_psa2imhi3udr9l71005ie8i7vv